Is Horizon Therapeutics PLC (HZNP) Stock Worth a Buy Wednesday?
Wednesday, September 15, 2021 03:20 PM | InvestorsObserver Analysts
Mentioned in this article
Horizon Therapeutics PLC (HZNP) stock is higher by 35.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HZNP stock a score of 72 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 77. HZNP's rank also includes a short-term technical score of 71. The fundamental score for HZNP is 68. In addition to the average rating from Wall Street analysts, HZNP stock has a mean target price of $131.30. This means analysts expect the stock to increase 23.16% over the next 12 months.
HZNP has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on HZNP!
Horizon Therapeutics PLC (HZNP) stock has gained 0.41% while the S&P 500 is higher by 0.92% as of 3:20 PM on Wednesday, Sep 15. HZNP is higher by $0.44 from the previous closing price of $106.17 on volume of 629,058 shares. Over the past year the S&P 500 is higher by 31.83% while HZNP is higher by 35.00%. HZNP earned $2.24 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 47.58.
Click Here to get the full Stock Report for Horizon Therapeutics PLC stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
